Loading…
CIK 0001274413 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("sectoral-asset-management-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ABBOTT LABS | COM | $2.9M | 2.4%Prev: 1.4% | 23,498 SH | Increased+6,300 SH |
| ABBVIE INC | COM | $3.8M | 3.1%Prev: 2.1% | 16,800 SH | Increased+2,000 SH |
| ALIGNMENT HEALTHCARE | COM | $622K | 0.5%Prev: 0.6% | 31,500 SH | Decreased-23,000 SH |
| ALNYLAM PHARMACEUTICALS INC | COM | $1.2M | 1.0% | 2,990 SH | New |
| AMGEN INC | COM | $4.3M | 3.4%Prev: 1.8% | 13,070 SH | Increased+2,730 SH |
| AMICUS THERAPEUTICS | COM | $617K | 0.5%Prev: 0.6% | 43,300 SH | Decreased-75,805 SH |
| ARCUS BIOSCIENCES | COM | $1.4M | 1.1%Prev: 3.1% | 56,945 SH | Decreased-311,125 SH |
| ARGENX SE SPN ADR | SP ADR | $2.4M | 2.0%Prev: 1.8% | 2,894 SH | Decreased-996 SH |
| ARRIVENT BIOPHARMA | COM | $770K | 0.6%Prev: 0.4% | 38,255 SH | Increased-980 SH |
| ARS PHARMACEUTICALS | COM | $347K | 0.3%Prev: 0.5% | 29,803 SH | Decreased-51,982 SH |
| ASCENDIS PHARMA | SP ADR | $694K | 0.6%Prev: 0.4% | 3,254 SH | Decreased-347 SH |
| ASTRAZENECA | SP ADR | $1.4M | 1.1%Prev: 0.9% | 15,232 SH | Decreased-3,518 SH |
| AXSOME THERAPEUTICS | COM | $318K | 0.3%Prev: 0.1% | 1,740 SH | Increased+720 SH |
| BEONE MEDICINES LTD | SP ADR | $810K | 0.6%Prev: 1.5% | 2,665 SH | Decreased-4,536 SH |
| BIOGEN INC | COM | $379K | 0.3%Prev: 0.2% | 2,155 SH | Increased-220 SH |
| BIOMARIN PHARMACEUTICAL INC | COM | $647K | 0.5% | 10,880 SH | New |
| BIONTECH SE | SP ADR | $1.6M | 1.3%Prev: 1.1% | 17,218 SH | Decreased-442 SH |
| BOSTON SCIENTIFIC | COM | $2.6M | 2.1%Prev: 1.3% | 27,626 SH | Increased+5,500 SH |
| BOUNDLESS BIO INC | COM | $814K | 0.7%Prev: 0.5% | 678,574 SH | Decreased |
| BRIDGEBIO PHARMA | COM | $854K | 0.7%Prev: 0.4% | 11,170 SH | Increased-2,480 SH |
| CARLSMED INC | COM | $589K | 0.5% | 47,700 SH | New |
| COGENT BIOSCIENCES INC | COM | $1.2M | 0.9% | 32,685 SH | New |
| CONTINEUM THERAPEUTICS | CL A | $9.2M | 7.3%Prev: 5.8% | 800,787 SH | Decreased |
| CYTOKINETICS INC | COM NEW | $374K | 0.3%Prev: 0.3% | 5,893 SH | Decreased-4,330 SH |
| DANAHER CORP | COM | $2.4M | 1.9%Prev: 1.3% | 10,575 SH | Increased |
| DEXCOM INC | COM | $1.9M | 1.5%Prev: 0.9% | 28,700 SH | Increased+8,000 SH |
| EDWARDS LIFESCIENCE | COM | $1.5M | 1.2%Prev: 0.7% | 17,250 SH | Increased+2,250 SH |
| ELI LILLY & CO | COM | $7.8M | 6.3%Prev: 4.4% | 7,276 SH | Increased-2,100 SH |
| EVOMMUNE INC | COM SHS | $10.1M | 8.1% | 589,005 SH | New |
| GILEAD SCIENCES INC | COM | $2.2M | 1.8%Prev: 1.3% | 17,885 SH | Increased-1,665 SH |
| HINGE HEALTH INC | CL A | $660K | 0.5%Prev: 0.3% | 14,206 SH | Increased+3,000 SH |
| ILLUMINA INC | COM | $324K | 0.3%Prev: 0.2% | 2,472 SH | Increased-255 SH |
| IMMATICS NV | SHS | $662K | 0.5%Prev: 2.9% | 63,015 SH | Decreased-497,479 SH |
| INCYTE CORPORATION | COM | $272K | 0.2%Prev: 0.2% | 2,750 SH | Increased-280 SH |
| INSMED INC | COM PAR $.01 | $1.9M | 1.6%Prev: 1.2% | 11,182 SH | Increased-2,243 SH |
| INSPIRE MED SYS INC | COM | $664K | 0.5% | 7,200 SH | New |
| INTUITIVE SURGIC INC | COM NEW | $2.7M | 2.2%Prev: 1.6% | 4,850 SH | Increased-900 SH |
| IONIS PHARMACEUTICAL | COM | $662K | 0.5%Prev: 0.4% | 8,365 SH | Increased-840 SH |
| JAZZ PHARMA PLC | SHS USD | $348K | 0.3%Prev: 0.2% | 2,049 SH | Increased-195 SH |
| JOHNSON & JOHNSON | COM | $4.2M | 3.4%Prev: 1.8% | 20,300 SH | Increased+5,000 SH |
| KURA ONCOLOGY | COM | $562K | 0.5%Prev: 2.2% | 54,110 SH | Decreased-341,762 SH |
| LENZ THERAPEUTICS INC | COM | $680K | 0.5% | 42,500 SH | New |
| MADRIGAL PHARMA | COM | $205K | 0.2%Prev: 0.2% | 352 SH | Decreased-378 SH |
| MERCK & CO INC | COM | $2.3M | 1.8%Prev: 0.9% | 21,400 SH | Increased+5,000 SH |
| MINERALYS THERAPEUTICS | COM | $1.1M | 0.9%Prev: 0.8% | 31,625 SH | Decreased-2,260 SH |
| MODERNA INC | COM | $148K | 0.1%Prev: 0.1% | 5,005 SH | Increased-595 SH |
| NEKTAR THERAPEUTICS | COM NEW | $570K | 0.5% | 13,485 SH | New |
| NEUROCRINE BIOSCIENCES | COM | $379K | 0.3%Prev: 0.3% | 2,675 SH | Decreased-285 SH |
| OMADA HEALTH INC | COM | $576K | 0.5%Prev: 0.4% | 36,500 SH | Decreased+9,000 SH |
| ORIC PHARMACEUTICALS | COM | $184K | 0.1%Prev: 2.4% | 22,480 SH | Decreased-306,175 SH |
| PFIZER INC | COM | $676K | 0.5%Prev: 1.2% | 27,150 SH | Decreased-50,000 SH |
| PRIVIA HEALTH GROUP | COM | $616K | 0.5%Prev: 0.6% | 26,000 SH | Decreased-10,500 SH |
| PTC THERAPEUTICS | COM | $586K | 0.5%Prev: 0.3% | 7,715 SH | Increased-820 SH |
| RADNET INC | COM | $785K | 0.6%Prev: 0.5% | 11,000 SH | Increased+1,000 SH |
| RAPPORT THERAPEUTICS | COM | $1.2M | 0.9%Prev: 0.8% | 38,925 SH | Decreased-4,555 SH |
| REGENERON PHARMCTCLS | COM | $2.9M | 2.3%Prev: 1.4% | 3,715 SH | Increased-253 SH |
| ROIVANT SCIENCES LTD | SHS | $984K | 0.8%Prev: 0.5% | 45,347 SH | Increased-4,660 SH |
| ROYALTY PHARMA PLC | SHS CLASS A | $327K | 0.3%Prev: 0.2% | 8,470 SH | Decreased-810 SH |
| SHOULDER INNOVATIONS | COMMON STOCK | $7.0M | 5.6%Prev: 3.3% | 492,435 SH | Increased+62,153 SH |
| STRUCTURE THERAPEUTICS | SP ADR | $1.7M | 1.3%Prev: 3.8% | 23,872 SH | Decreased-198,000 SH |
| STRYKER CORP | COM | $2.3M | 1.8%Prev: 1.0% | 6,550 SH | Increased+2,250 SH |
| SUMMIT THERAPEUTICS | COM | $1.4M | 1.1%Prev: 0.9% | 79,625 SH | Decreased+5,555 SH |
| SYNDAX PHARMACEUTICALS | COM | $1.3M | 1.0%Prev: 0.8% | 61,200 SH | Increased-18,230 SH |
| TARSUS PHARMACEUTICAL | COM | $1.2M | 1.0%Prev: 0.7% | 14,740 SH | Increased-3,665 SH |
| TECTONIC THERAPEUTICS | COM | $881K | 0.7% | 42,255 SH | New |
| TEMPUS AI INC | CL A | $266K | 0.2%Prev: 0.2% | 4,500 SH | Decreased+740 SH |
| THERMO FISHER SCIENTIFIC | COM | $2.3M | 1.8%Prev: 1.2% | 3,900 SH | Increased |
| TREVI THERAPEUTIC INC | COM | $1.1M | 0.8% | 84,255 SH | New |
| UNIQURE N.V. | SHS | $732K | 0.6%Prev: 1.1% | 30,585 SH | Decreased-155 SH |
| UNITED THERAPEUTICS | COM | $840K | 0.7%Prev: 0.2% | 1,723 SH | Increased+958 SH |
| UNITEDHEALTH GRP INC | COM | $4.5M | 3.6%Prev: 2.9% | 13,595 SH | Decreased+50 SH |
| VENTYX BIOSCIENCES | COM | $875K | 0.7%Prev: 2.1% | 96,945 SH | Decreased-1,010,322 SH |
| VERA THERAPEUTICS | CL A | $1.9M | 1.5%Prev: 0.5% | 36,858 SH | Increased+6,670 SH |
| VERTEX PHARMA | COM | $3.6M | 2.9%Prev: 1.9% | 8,005 SH | Increased+290 SH |
| 13F-HR |
| 0001104659-26-096554 |
| $143.3M |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0001104659-25-078356 | $151.5M | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0001104659-26-062046 | $120.7M | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0001104659-25-049125 | $128.5M | View |